Premium
EFFECTS OF GAMMA‐HYDROXYBUTYRIC ACID AND OTHER HYPNOTICS ON GLUCOSE UPTAKE IN VIVO AND IN VITRO
Author(s) -
Taberner P. V.
Publication year - 1973
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.1973.tb00027.x
Subject(s) - in vivo , acetic acid , glycogen , glucose uptake , chemistry , in vitro , carbohydrate metabolism , glutamate receptor , medicine , endocrinology , biochemistry , pharmacology , biology , insulin , receptor , microbiology and biotechnology
— (1) The effects of gamma‐hydroxybutyrate, imidazole‐4‐acetic acid and pento‐barbitone on mouse brain glucose, glycogen and lactate levels have been studied. All the drugs significantly increased the brain glucose content, but did not significantly alter brain glycogen levels. The increase in brain glucose following imidazole‐4‐acetic acid or hypnotic doses of pentobarbitone was matched by corresponding decreases in the lactate level; this was not the case with gamma‐hydroxybutyrate where the total glucose equivalents in the brain, expressed as the tissue level of (glucose) + (lactate/2), were significantly increased. (2) All drugs except imidazole‐4‐acetic acid significantly decreased the rate of appearance of [ 14 C]glucose into the bloodstream in vivo but had no effect on the uptake of glucose into rat diaphragm in vitro when present at 2·5 mM concentration. (3) Only imidazole‐4‐acetic acid significantly inhibited glucose uptake into the brain in vivo but at 2·5 mM had no significant effect on glucose uptake into rat cerebral cortical slices in vitro. (4) It is concluded that the very large increase in brain glucose level observed following the injection of hypnotic doses of gamma‐hydroxybutyrate cannot be explained in terms of an increased net uptake of glucose into the brain.